The Multicenter Automatic Defibrillator Implantation Trial

Abstract

Get full access to this article

View all access options for this article.

References

Solvd investigators . Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325:293, 1991

Solvd investigators . Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327:685, 1992

Farrell TG , Bashir Y. , Cripps T. , et al. Risk stratification for arrhythmic events in post infarction patients based on heart rate variability, ambulatory electrocardiographic variables and signal averaged electrocardiogram. J Am Coll Cardiol 18:687, 1991

Garg R. , Yusuf S for the collaborative group on ACE inhibitor trials. Overview of randomised trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 273:1450, 1995

Singh SN , Fletcher RD , Fisher SG , et al. For the Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 333:77, 1995

Julian DG , Camm AJ , Frangin G. , Janse MJ , Munoz A. , Schwartz PJ , Singh P. , for the EMIAT investigators. Randomized trial of effect of amiodarone on mortality in patients with left ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 349:667, 1997

Cairns JA , Connolly SJ , Roberts R. , Gent M. , for the CAMIAT Investigators. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 349:675, 1997

Gottlieb S. Dead is dead: artificial definitions are no substitute. Lancet 349:662, 1997

Stevenson WG Ridker PM Should survivors of myocardial infarction with low ejection fraction be routinely referred to arrhythmia specialists ? JAMA 276:481, 1996

10.

Moss AJ , Hall WJ , Cannom DS , et al. and the MADIT Investigators. Improved survival with an implanted defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmia. N Engl J Med 335:1933, 1996

11.

Pedretti R. Etro MD, Laporta A, Braga SS, Carz B. Prediction of late arrhythmic events after acute myocardial infarction from combined use of noninvasive prognostic variables and inducibility of sustained monomorphic ventricular tachycardia. Am J Cardiol 71:1131, 1993

12.

Gradman A. , Deedwania P. , Cody R. , et al. for the Captopril-Digoxin Study Group. Predictors of total mortality and sudden death in mild to moderate heart failure . J Am Coll Cardiol 14:564, 1989

13.

Richards Dab , Byth K. , Ross DL , Uther JB

What is the best predictor of spontaneous ventricular tachycardia and sudden death after myocardial infarction?

Circulation 83: 756, 1991

14.

Iesaka Y. , Nogami A. , Aonuma K. , Nitta J. , Chun YH , Fujiwara H. , Hiraoka M. Prognostic significance of sustained monomorphic ventricular tachycardia induced by programmed ventricular stimulation using up to triple extra-stimuli in survivors of acute myocardial infarction. Am J Cardiol 65:1057, 1990

15.

Wilber DJ , Olshansky B. , Moran JF , Scanlon PJ Electrophysiological testing and nonsustained ventricular tachycardia: use and limitations in patients with coronary artery disease and impaired ventricular function. Circulation 82:350, 1990

16.

Saksena S. , Moss A. , Giorgberidze I. , Lewis C. , Zareba W. , Brown M. , for the MADIT Investigators. Factors associated with shock delivery in the Multicenter Automatic Defibrillator Implantation Trial [MADIT].(Abstract) J Am Coll Cardiol 29(suppl A):79A, 1997

17.

The ESVEM Investigators. The ESVEM Trial: electrophysiologic study versus electrocardiographic monitoring for selection of antiarrhythmic therapy of ventricular tachyarrhythmias . Circulation 79:1354, 1989

18.

Friedman P. , Stevenson WG Unsustained ventricular tachycardia—to treat or not to treat. N Engl J Med 335: 1984, 1996

19.

Saksena S. , Madan N. , Lewis C. Implantable cardioverter defibrillators are preferable to drugs as primary therapy in sustained ventricular tachyarrhythmias. Prog Cardiovasc Dis 38:445, 1996

20.

Saksena S. , Breithardt GB , Dorian P. , Greene HL , Madan N. , Block M. Nonpharmacological therapy for malignant ventricular arrhythmias: implantable defibrillator trials. Prog Cardiovasc Dis 38:429, 1996

21.

Saksena S. , Giorgberidze I. , Krol RB , et al. Risk stratification and clinical outcome of patients with minially symptomatic or asymptomatic ventricular tachycardia and coronary disease: a prospective single center study. Am J Cardiol (in press), 1997

22.

Daubert JP , Higgins SL , Zareba W. , Wilber DJ Comparative survival of MADIT: eligible but noninducible patients. (Abstract) J Am Coll Cardiol 29(suppl A):78A, 1997

23.

Giorgberidze I. , Saksena S. , Lewis C. , et al. Sudden death after "conventional" therapy in patients excluded from MADIT. PACE (Abstract) 20:1086, 1997

24.

Luu M. , Stevenson WG , Stevenson LW , Baron K. , Walden J. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure . Circulation 80:1675, 1989

25.

Bocker D. , Block M. , Weber M. , et al. Benefit from ICD implantation in patients with heart failure . PACE (Abstract) 20:149, 1997